Broadway's 'Just in Time' Recoups $12.5 Million, Turning Profit After Jonathan Groff Run
Updated
Updated · The New York Times · May 18
Broadway's 'Just in Time' Recoups $12.5 Million, Turning Profit After Jonathan Groff Run
1 articles · Updated · The New York Times · May 18
$12.5 million in capitalization costs has been fully recouped by Bobby Darin musical "Just in Time," allowing the Broadway production to repay investors and begin sharing profits.
Jonathan Groff's first-year run drove the show to that milestone: during his final week in late March, grosses topped $2 million, best seats reached $1,477, and the average ticket price hit $362.
Grosses have eased since Groff left, but the 690-seat Circle in the Square production was sold out last week and is still taking in more than its weekly running costs most weeks.
The result defied early skepticism that Darin was too obscure to sell tickets; the show opened in April 2025, missed a best musical Tony nomination, and won none of its six nominations.
Producers now hope the lower-cost show can run indefinitely on Broadway and launch a North American tour next summer.
How did a musical with no Tony Awards become Broadway's most surprising financial hit of the season?
After its star's exit, can the profitable Bobby Darin biomusical sustain its success on Broadway's competitive stage?